Details for New Drug Application (NDA): 022088

✉ Email this page to a colleague

NDA 022088 describes TORISEL, which is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from one supplier. There are five patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TORISEL profile page.

The generic ingredient in TORISEL is temsirolimus. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the temsirolimus profile page.

Summary for 022088

Tradename:	TORISEL
Applicant:	Pf Prism Cv
Ingredient:	temsirolimus
Patents:	5

Suppliers and Packaging for NDA: 022088

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TORISEL	temsirolimus	SOLUTION;INTRAVENOUS	022088	NDA	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	0008-1179	0008-1179-01	1 KIT in 1 CARTON (0008-1179-01) * 25 mL in 1 VIAL, SINGLE-USE (0008-1279-01) * 1.8 mL in 1 VIAL, SINGLE-USE (0008-1125-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INTRAVENOUS			Strength	25MG/ML (25MG/ML)
Approval Date:	May 30, 2007	TE:	AP	RLD:	Yes
Patent:	⤷ Subscribe	Patent Expiration:	Jul 20, 2026	Product Flag?		Substance Flag?		Delist Request?	Y
Patent:	⤷ Subscribe	Patent Expiration:	Jan 25, 2024	Product Flag?		Substance Flag?		Delist Request?
Patent:	⤷ Subscribe	Patent Expiration:	Jan 25, 2024	Product Flag?		Substance Flag?		Delist Request?

Expired US Patents for NDA 022088

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pf Prism Cv	TORISEL	temsirolimus	SOLUTION;INTRAVENOUS	022088-001	May 30, 2007	⤷ Subscribe	⤷ Subscribe
Pf Prism Cv	TORISEL	temsirolimus	SOLUTION;INTRAVENOUS	022088-001	May 30, 2007	⤷ Subscribe	⤷ Subscribe
Pf Prism Cv	TORISEL	temsirolimus	SOLUTION;INTRAVENOUS	022088-001	May 30, 2007	⤷ Subscribe	⤷ Subscribe
Pf Prism Cv	TORISEL	temsirolimus	SOLUTION;INTRAVENOUS	022088-001	May 30, 2007	⤷ Subscribe	⤷ Subscribe
Pf Prism Cv	TORISEL	temsirolimus	SOLUTION;INTRAVENOUS	022088-001	May 30, 2007	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.